- Home
- PRA vs ATAI Comparison
PRA vs ATAI Comparison
Compare PRA & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRA
- ATAI
- Stock Information
- Founded
- PRA 1976
- ATAI 2018
- Country
- PRA United States
- ATAI Netherlands
- Employees
- PRA N/A
- ATAI N/A
- Industry
- PRA Property-Casualty Insurers
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- PRA Finance
- ATAI Health Care
- Exchange
- PRA Nasdaq
- ATAI Nasdaq
- Market Cap
- PRA 1.2B
- ATAI 1.1B
- IPO Year
- PRA N/A
- ATAI 2021
- Fundamental
- Price
- PRA $23.97
- ATAI $5.86
- Analyst Decision
- PRA Hold
- ATAI Strong Buy
- Analyst Count
- PRA 4
- ATAI 5
- Target Price
- PRA $21.00
- ATAI $14.00
- AVG Volume (30 Days)
- PRA 420.0K
- ATAI 7.1M
- Earning Date
- PRA 11-05-2025
- ATAI 11-14-2025
- Dividend Yield
- PRA N/A
- ATAI N/A
- EPS Growth
- PRA N/A
- ATAI N/A
- EPS
- PRA 0.95
- ATAI N/A
- Revenue
- PRA $1,128,928,000.00
- ATAI $2,309,000.00
- Revenue This Year
- PRA N/A
- ATAI $736.04
- Revenue Next Year
- PRA N/A
- ATAI N/A
- P/E Ratio
- PRA $25.39
- ATAI N/A
- Revenue Growth
- PRA N/A
- ATAI 510.85
- 52 Week Low
- PRA $13.00
- ATAI $1.04
- 52 Week High
- PRA $24.22
- ATAI $6.75
- Technical
- Relative Strength Index (RSI)
- PRA 45.71
- ATAI 54.54
- Support Level
- PRA $24.05
- ATAI $5.50
- Resistance Level
- PRA $24.17
- ATAI $6.23
- Average True Range (ATR)
- PRA 0.09
- ATAI 0.49
- MACD
- PRA -0.01
- ATAI -0.03
- Stochastic Oscillator
- PRA 25.93
- ATAI 48.05
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.